• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS- ADVANCED PERFUSION SYSTEM 1

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION ADVANCED PERFUSION SYSTEM 1; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS- ADVANCED PERFUSION SYSTEM 1 Back to Search Results
Model Number 801188
Device Problem Gas Output Problem (1266)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/18/2019
Event Type  malfunction  
Manufacturer Narrative
Per data log analysis, on (b)(6) 2019, there is no indication of a problem in the gas system log.There is one instance where fio2 was changed from 60.9% to 24.7%.This change was from a local knob turn.The field service representative (fsr) completed testing without finding any issues.He discussed the log analysis with the perfusionist.The unit operated to the manufacturer's specifications.
 
Event Description
It was reported that during use of the device for a cardiopulmonary bypass (cpb) procedure, the fraction of inspired oxygen (fio2) of the unit changed down to 21% on its own.The fio2 was adjusted back to the desired setting.The surgical procedure was completed successfully.There was no delay, no blood loss, nor adverse consequences to the patient.
 
Event Description
Per clinical review: the issue was discovered on november 18, 2019 during a cardiopulmonary bypass procedure (cpb) on (b)(6) 2019.The team set up and calibrated the unit without issue for the case.During the case, the team stated that the fraction of inspired oxygen (fio2) had changed down to 21% on its own, but per the log data obtained from the unit, the change was from a manual knob adjust from 60.9% fio2 to 24.7% fio2.The fio2 once noticed that it was at a low level was then increased to the appropriate level, and the case proceeded without any additional issues regarding the fio2 output.The unit was not exchanged during the procedure, and the electronic patient gas system (epgs) worked as expected the remainder of the case.There was no delay in the surgical procedure.There was no harm or blood loss related to the incident.
 
Manufacturer Narrative
The reported complaint was confirmed.If additional information becomes available on this complaint that would alter the facts and/or conclusion, a supplemental report will be filed accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCED PERFUSION SYSTEM 1
Type of Device
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS- ADVANCED PERFUSION SYSTEM 1
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
6200 jackson road
ann arbor MI 48103
MDR Report Key9451538
MDR Text Key199112635
Report Number1828100-2019-00654
Device Sequence Number1
Product Code DTQ
UDI-Device Identifier00886799000588
UDI-Public(01)00886799000588(11)090211
Combination Product (y/n)N
PMA/PMN Number
K172220
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 02/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number801188
Device Catalogue Number801188
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-